Compare RDY & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | NVT |
|---|---|---|
| Founded | 1984 | 1903 |
| Country | India | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 18.1B |
| IPO Year | N/A | N/A |
| Metric | RDY | NVT |
|---|---|---|
| Price | $14.19 | $107.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $16.90 | ★ $107.58 |
| AVG Volume (30 Days) | 938.9K | ★ 2.2M |
| Earning Date | 01-22-2026 | 10-31-2025 |
| Dividend Yield | 0.50% | ★ 0.74% |
| EPS Growth | ★ 9.95 | 6.36 |
| EPS | 0.79 | ★ 3.64 |
| Revenue | ★ $3,851,623,984.00 | $3,578,600,000.00 |
| Revenue This Year | $6.16 | $28.70 |
| Revenue Next Year | $2.57 | $14.60 |
| P/E Ratio | ★ $17.87 | $60.23 |
| Revenue Growth | 14.10 | ★ 21.54 |
| 52 Week Low | $12.26 | $41.71 |
| 52 Week High | $16.17 | $117.52 |
| Indicator | RDY | NVT |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 54.94 |
| Support Level | $13.64 | $102.25 |
| Resistance Level | $14.20 | $108.89 |
| Average True Range (ATR) | 0.16 | 3.74 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 98.25 | 76.57 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.